Renewable energy

IVIG products to occupy 60% of global immunoglobulin products market by 2020

  Immunoglobulin: key market research findings Increased use of synthetic/recombinant products Promising clinical pipeline Technavio has released a new market research report on the global immunoglobulin products market, which is expected to grow at a CAGR of around 7% between 2016 and 2020. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency…

Read More
Renewable energy

Global ADC market set to grow at a CAGR of 42% by 2020, owing to its robust late-stage pipeline

  ADCs: Key market research findings Emergence of targeted and combination therapies Growing usage of IgG antibodies Technavio has released a new market research report on the global ADCs market, which is expected to generated revenues of $7 billion between 2016 and 2020. Individuals detected with cancer are preferring antibody-drug conjugates (ADCs) than other mAbs…

Read More
Renewable energy

Technavio says global type 2 diabetes drugs market to surpass $53 billion by 2020

  This market research study presents a detailed segmentation of the global type 2 diabetes drugs market by drug class (insulin, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors, and others) and by geography (Americas, APAC, and EMEA). The top vendors identified in the market are Novo Nordisk, Sanofi, Merck, Eli Lily, and AstraZeneca. Technavio’s market…

Read More
Renewable energy

Technavio says global Type 1 diabetes drugs market to exceed $63 billion by 2020

  This market research study presents a detailed segmentation of the global type I diabetes drugs market by drug class (insulin and others), and geographical segmentation (Americas, APAC, and EMEA). The top vendors identified in the market are Novo Nordisk, Sanofi, and Eli Lily Technavio’s market research analysts estimate the global Type 1 diabetes drugs…

Read More
Renewable energy

Technavio says global heparin market to witness anti-inflammatory and anti-metastatic properties of heparin by 2020

  This market research report presents a detailed analysis of the key drivers and trends that influence market growth. It also segments the global heparin market by product type (LMWH and others), by route of administration (IV injection/infusion and SC injection), and by geography (the Americas, APAC, and EMEA). The key leading vendors analyzed in…

Read More
Renewable energy

Formation of strategic alliances between manufacturers to foster growth in the global myocardial infarction drugs market

  Myocardial infarction drugs: Key market research findings Strategic alliances to help in the co-development and commercialization of drugs Extensive use of stent grafts to impel the prospects for market growth Technavio has released a new market research report on the global myocardial infarction drugs market, which is expected to surpass $5 billion by 2020….

Read More
Renewable energy

Shifting focus toward untapped markets will help global peptide therapeutics market cross $29 billion by 2020

  This market research report includes a detailed segmentation of the global peptide therapeutics market by route of administration (parenteral, oral, pulmonary, and mucosal), by drug class (somatostatins, vasopressin, calcitonin, LHRH, glucagon and analogs, and insulins), and by synthesis technology (liquid-phase peptide synthesis, solid-phase peptide synthesis, and hybrid peptide synthesis). The top vendors analyzed in…

Read More
Renewable energy

Surge in OTC drug sales will help global consumer healthcare market cross $360 billion by 2020

  The global consumer healthcare market is segmented by products (OTC pharmaceuticals and dietary supplements) and by geography (The Americas, APAC and EMEA). This research report analyses the market shares of leading vendors including Bayer HealthCare, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi. Technavio’s market research analysts estimate the global consumer healthcare market,…

Read More
Renewable energy

Technavio expects global RA market to reach $32 billion by 2020, thanks to the growing popularity of biosimilars and off-label treatment options

  Rheumatoid Arthritis (RA): Key market research findings Increasing use of biosimilars over biologics Popularity of off-label and traditional treatment options Technavio has released a new market research report on the global RA market, which is expected to grow at a CAGR of more than 3% by 2020. RA is a chronic inflammatory autoimmune disease,…

Read More
Renewable energy

Combination therapies prove to be more effective in choroidal neovascularization treatment

  This market research report includes a detailed segmentation of the global choroidal neovascularization market by route of administration (IV and Intravitreal) and by geography (Americas, EMEA and APAC). The top vendors analyzed in this report are Bayer, F. Hoffmann-La Roche, Novartis, and Regeneron Pharmaceuticals. Technavio’s market research analysts estimate the global choroidal neovascularization market,…

Read More